Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7407785 Human DNase I hyperactive variants

Patent 7407785 was granted and assigned to Genentech on August, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 30 Oct, 2024

"update inverses"

edited on 30 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12129288 Polynucleotides heterodimers of soluble interferon receptors and uses thereof

0

Edits on 4 Sep, 2024

"update inverses"

edited on 4 Sep, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12077790 Optimized binuclease fusions and methods

0

Edits on 14 Sep, 2023

"Add patent abstract"

edited on 14 Sep, 2023

Edits made to:

Article (+434 characters)

Article

Patent abstract

The present invention relates to amino acid sequence variants of human DNase I that have increased DNA-hydrolytic activity. The invention provides nucleic acid sequences encoding such hyperactive variants, thereby enabling the production of these variants in quantities sufficient for clinical use. The invention also relates to pharmaceutical compositions and therapeutic uses of hyperactive-variants of human DNase I.

Edits on 7 Jun, 2023

"update inverses"

edited on 7 Jun, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11667890 Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

0

Edits on 22 May, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 22 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=0740778500

Edits on 18 May, 2023

"Remove leading 0 from patent number"

edited on 18 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 07407785 Human DNase I hyperactive variants US Patent 7407785 Human DNase I hyperactive variants

Infobox

Patent Number

0740778500

Patent Number

740778500

Edits on 21 Mar, 2023

"Entity importer update"

edited on 21 Mar, 2023

Infobox

Is a

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

074077850

Date of Patent

August 5, 2008

0

Patent Application Number

108386910

Date Filed

May 3, 2004

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=074077850

Patent Primary Examiner

Delia M. Ramirez

0

Edits on 25 Sep, 2022

"Entity importer update"

edited on 25 Sep, 2022

Infobox

Is a

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

074077850

Date of Patent

August 5, 2008

0

Patent Application Number

108386910

Date Filed

May 3, 2004

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=074077850

Patent Primary Examiner

Delia M. Ramirez

0

Edits on 9 Jun, 2022

"Entity importer update"

edited on 9 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=07407785

Edits on 1 Dec, 2021

"Created via: Entity Importer"

created this topic on 1 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 07407785 Human DNase I hyperactive variants

Infobox

Is a

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

07407785

Date of patent

August 5, 2008

Patent application number

10838691

Date Filed

May 3, 2004

Patent primary examiner

Delia M. Ramirez

Find more entities like US Patent 7407785 Human DNase I hyperactive variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.